Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies.
By H. Mahrholdt, A. Wagner, R. Judd, U. Sechtem, R. Kim. European Heart Journal, 2005
870 citations recorded by the source corpus.
Subfields: Cardiology and Cardiovascular Medicine, Radiology, Nuclear Medicine and Imaging
View Paper: https://www.semanticscholar.org/paper/be7da8480d76fefe328b982c1e746ed1809a46c9
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cardiology and Cardiovascular Medicine
In Radiology, Nuclear Medicine and Imaging
Citations in the corpus
- Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement (2013, background): “ECV can be measured in areas of LGE; [75,76] although for ischaemic heart disease, it may reflect pathology better to dichotomise measurement into “infarct” and “remote”.”
- Troponin elevation in coronary vs. non-coronary disease. (2011, background): “Delayed enhancement usually involves the subendocardial layer in MI, whereas it usually spares the subendocardial layer in myocarditis.(46,47)”
- Assessment of Myocardial Fibrosis with Cardiac Magnetic Resonance (2011, background): “Recent reports have demonstrated the advantages of using cardiovascular magnetic resonance (CMR) for the noninvasive imaging of heart failure patients (14,15).”
- Association of fibrosis with mortality and sudden cardiac death in patients with nonischemic dilated cardiomyopathy. (2013, neutral): “13,14 Approximately 30% of patients with dilated cardiomyopathy have a characteristic midwall pattern of replacement fibrosis on LGE-CMR.”
- Standardized image interpretation and post processing in cardiovascular magnetic resonance: Society for Cardiovascular Magnetic Resonance (SCMR) Board of Trustees Task Force on Standardized Post Processing (2013, background): “c) Criteria for presence of LGE i) High SI area that may be as bright as the LV blood pool ii) Rule out artifacts (see below) d) Assess pattern of LGE i) Coronary artery disease (CAD) type: Should involve the subendocardium and be consistent with a coronary artery perfusion territory ii) Non-CAD-typ”